Healthcare Sector Stocks
The Healthcare sector has a total of 1058 stocks, with a combined market cap of $8.42 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 41.76.
Market Cap
8.42T
Revenue
4.59T
Profits
201.5B
PE Ratio
41.76
Profit Margin
4.39%
Dividend Yield
0.42%
1058 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.01T | 4.68% | 1,104,301 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 547.98B | 1.97% | 1,296,641 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 390.67B | 1.84% | 1,263,683 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 361.31B | 5.53% | 3,491,964 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 293.82B | 3.72% | 2,124,310 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 275.27B | 2.91% | 454,870 | 60.44B |
| 7 | NVS | Novartis AG | 262.89B | 2.34% | 451,918 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 187.14B | 4.64% | 4,226,290 | 50.57B |
| 9 | AMGN | Amgen Inc. | 185.76B | 1.77% | 532,853 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 180.25B | 2.34% | 393,220 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 160.11B | -0.02% | 1,495,932 | 29.74B |
| 12 | ABT | Abbott Laboratories | 158.35B | 4.51% | 5,222,968 | 45.13B |
| 13 | ISRG | Intuitive Surgical, Inc. | 147.83B | 2.48% | 601,861 | 10.58B |
| 14 | PFE | Pfizer Inc. | 146.79B | 1.64% | 6,798,800 | 63.32B |
| 15 | DHR | Danaher Corporation | 131.40B | 4.25% | 1,174,354 | 24.78B |
| 16 | CVS | CVS Health Corporation | 120.08B | 3.00% | 3,702,559 | 405.62B |
| 17 | SYK | Stryker Corporation | 115.76B | 2.36% | 469,978 | 25.27B |
| 18 | BMY | Bristol-Myers Squibb Company | 114.68B | 2.63% | 2,916,323 | 48.48B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 112.28B | 3.28% | 279,908 | 12.22B |
| 20 | MDT | Medtronic plc | 105.28B | 5.20% | 4,599,308 | 36.36B |
| 21 | SNY | Sanofi | 102.43B | 4.67% | 781,124 | 54.60B |
| 22 | GSK | GSK plc | 99.30B | 2.13% | 827,608 | 43.29B |
| 23 | MCK | McKesson Corporation | 91.03B | 2.40% | 162,337 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 88.66B | 4.34% | 317,161 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 81.16B | 0.73% | 311,630 | 76.39B |
| 26 | CI | The Cigna Group | 74.59B | 4.16% | 317,589 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 72.62B | 2.45% | 6,184,391 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 63.46B | 0.78% | 170,325 | 14.92B |
| 29 | COR | Cencora, Inc. | 52.33B | 2.03% | 212,602 | 328.68B |
| 30 | EW | Edwards Lifesciences Corporation | 50.42B | 1.81% | 702,490 | 6.30B |
| 31 | ARGX | argenx SE | 50.20B | 3.37% | 76,232 | 4.74B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 47.90B | 2.86% | 611,973 | 28.34B |
| 33 | CAH | Cardinal Health, Inc. | 47.01B | 2.48% | 477,757 | 250.74B |
| 34 | MDLN | Medline Inc. | 45.34B | 0.12% | 1,664,580 | 29.14B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 44.78B | 1.24% | 123,636 | 4.45B |
| 36 | HUM | Humana Inc. | 41.89B | 6.53% | 436,155 | 137.20B |
| 37 | BDX | Becton, Dickinson and Company | 41.46B | 3.32% | 416,579 | 22.23B |
| 38 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.01B | 4.99% | 259,475 | 4.29B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 39.56B | 3.47% | 1,532,483 | 17.35B |
| 40 | A | Agilent Technologies, Inc. | 39.55B | 1.91% | 235,573 | 7.23B |
| 41 | HLN | Haleon plc | 38.23B | 2.24% | 1,573,498 | 14.85B |
| 42 | WAT | Waters Corporation | 37.49B | 0.55% | 134,405 | 3.77B |
| 43 | ZTS | Zoetis Inc. | 33.92B | 4.28% | 1,755,833 | 9.53B |
| 44 | RVMD | Revolution Medicines, Inc. | 33.50B | 1.02% | 399,354 | - |
| 45 | NTRA | Natera, Inc. | 32.22B | 6.19% | 216,305 | 2.50B |
| 46 | RPRX | Royalty Pharma plc | 32.02B | 1.17% | 491,096 | 2.44B |
| 47 | ALC | Alcon Inc. | 31.50B | 2.76% | 545,754 | 10.63B |
| 48 | ONC | BeOne Medicines AG | 31.37B | 1.13% | 29,242 | 5.70B |
| 49 | IQV | IQVIA Holdings Inc. | 31.35B | 3.17% | 406,069 | 16.63B |
| 50 | CNC | Centene Corporation | 31.24B | 6.22% | 1,040,866 | 178.33B |
| 51 | VEEV | Veeva Systems Inc. | 29.43B | 0.91% | 1,265,445 | 3.32B |
| 52 | BIIB | Biogen Inc. | 29.33B | 1.38% | 115,028 | 9.94B |
| 53 | GEHC | GE HealthCare Technologies Inc. | 29.20B | 3.48% | 760,878 | 20.98B |
| 54 | DXCM | DexCom, Inc. | 28.38B | 1.09% | 703,788 | 4.82B |
| 55 | RMD | ResMed Inc. | 27.95B | 3.33% | 303,596 | 5.54B |
| 56 | ILMN | Illumina, Inc. | 26.59B | 2.81% | 475,871 | 4.39B |
| 57 | PHG | Koninklijke Philips N.V. | 24.17B | 2.13% | 291,773 | 20.34B |
| 58 | MTD | Mettler-Toledo International Inc. | 23.95B | 1.37% | 24,698 | 4.09B |
| 59 | UTHR | United Therapeutics Corporation | 23.19B | -0.58% | 65,407 | 3.17B |
| 60 | BNTX | BioNTech SE | 22.95B | 2.60% | 222,154 | 3.23B |
| 61 | INSM | Insmed Incorporated | 22.63B | 0.53% | 271,127 | 819.56M |
| 62 | WST | West Pharmaceutical Services, Inc. | 22.55B | 0.93% | 56,686 | 3.22B |
| 63 | DGX | Quest Diagnostics Incorporated | 22.20B | 3.53% | 180,784 | 11.28B |
| 64 | LH | Labcorp Holdings Inc. | 21.89B | 3.12% | 89,271 | 14.14B |
| 65 | ROIV | Roivant Sciences Ltd. | 21.04B | 1.92% | 384,778 | 8.26M |
| 66 | STE | STERIS plc | 20.97B | 2.19% | 87,251 | 5.94B |
| 67 | MRNA | Moderna, Inc. | 20.48B | 5.20% | 1,753,065 | 2.23B |
| 68 | INCY | Incyte Corporation | 20.07B | 2.53% | 305,295 | 5.36B |
| 69 | VTRS | Viatris Inc. | 18.28B | 0.90% | 1,379,052 | 14.56B |
| 70 | GH | Guardant Health, Inc. | 17.56B | 4.23% | 363,647 | 1.08B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 16.91B | 2.85% | 252,216 | 8.41B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 16.86B | 1.57% | 311,178 | 3.10B |
| 73 | JAZZ | Jazz Pharmaceuticals plc | 14.72B | 1.59% | 189,047 | 4.44B |
| 74 | GMAB | Genmab A/S | 14.53B | 2.81% | 336,379 | 3.90B |
| 75 | SOLV | Solventum Corporation | 14.18B | 4.53% | 516,432 | 8.26B |
| 76 | THC | Tenet Healthcare Corporation | 14.02B | -1.26% | 162,186 | 21.46B |
| 77 | ASND | Ascendis Pharma A/S | 13.68B | 1.57% | 98,107 | 998.25M |
| 78 | BBIO | BridgeBio Pharma, Inc. | 13.23B | 3.16% | 295,799 | 579.96M |
| 79 | MEDP | Medpace Holdings, Inc. | 13.12B | 1.88% | 24,553 | 2.68B |
| 80 | EXEL | Exelixis, Inc. | 13.05B | 0.64% | 315,060 | 2.38B |
| 81 | ELAN | Elanco Animal Health Incorporated | 12.86B | 4.76% | 2,234,103 | 4.89B |
| 82 | DVA | DaVita Inc. | 12.72B | 1.59% | 88,472 | 13.84B |
| 83 | SNN | Smith & Nephew plc | 12.72B | 1.95% | 592,943 | 6.16B |
| 84 | PEN | Penumbra, Inc. | 12.61B | 0.40% | 232,755 | 1.45B |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | 12.49B | 2.38% | 131,759 | 1.06B |
| 86 | COO | The Cooper Companies, Inc. | 12.22B | 3.76% | 797,727 | 4.15B |
| 87 | BTSG | BrightSpring Health Services, Inc. | 12.21B | -2.48% | 3,780,114 | 13.65B |
| 88 | AXSM | Axsome Therapeutics, Inc. | 12.14B | 1.07% | 181,995 | 708.24M |
| 89 | ALGN | Align Technology, Inc. | 12.01B | 3.74% | 182,913 | 4.10B |
| 90 | RGC | Regencell Bioscience Holdings Limited | 11.64B | -1.09% | 19,536 | - |
| 91 | ICLR | ICON Public Limited Company | 11.56B | 4.93% | 325,086 | 8.25B |
| 92 | RVTY | Revvity, Inc. | 11.49B | 1.94% | 176,278 | 2.90B |
| 93 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.46B | 1.81% | 33,495 | 1.13B |
| 94 | SMMT | Summit Therapeutics Inc. | 11.38B | -2.72% | 937,325 | - |
| 95 | FMS | Fresenius Medical Care AG | 11.23B | 5.31% | 199,651 | 22.32B |
| 96 | RDY | Dr. Reddy's Laboratories Limited | 11.01B | 1.69% | 154,676 | 3.58B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.98B | 3.90% | 353,279 | 3.24B |
| 98 | GMED | Globus Medical, Inc. | 10.92B | 3.18% | 131,669 | 3.10B |
| 99 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.42B | 1.98% | 229,462 | 622.01M |
| 100 | PODD | Insulet Corporation | 10.38B | 4.54% | 276,171 | 2.90B |
| 101 | EHC | Encompass Health Corporation | 10.38B | 1.38% | 80,447 | 6.07B |
| 102 | MOH | Molina Healthcare, Inc. | 10.09B | 4.77% | 183,650 | 43.10B |
| 103 | BAX | Baxter International Inc. | 9.91B | 3.53% | 1,127,461 | 11.32B |
| 104 | CYTK | Cytokinetics, Incorporated | 9.76B | 1.68% | 187,178 | 105.82M |
| 105 | ENSG | The Ensign Group, Inc. | 9.76B | 1.00% | 53,961 | 5.27B |
| 106 | BRKR | Bruker Corporation | 9.65B | 1.13% | 1,247,825 | 3.46B |
| 107 | MASI | Masimo Corporation | 9.36B | 0.03% | 100,814 | 1.56B |
| 108 | TEM | Tempus AI, Inc. | 9.27B | 8.61% | 3,483,621 | 1.36B |
| 109 | KRYS | Krystal Biotech, Inc. | 9.17B | 3.04% | 63,533 | 417.30M |
| 110 | UHS | Universal Health Services, Inc. | 8.90B | 0.67% | 99,776 | 17.76B |
| 111 | CRL | Charles River Laboratories International, Inc. | 8.89B | 2.67% | 152,229 | 4.03B |
| 112 | HSIC | Henry Schein, Inc. | 8.79B | 1.87% | 169,002 | 13.38B |
| 113 | HALO | Halozyme Therapeutics, Inc. | 8.45B | 1.99% | 337,108 | 1.51B |
| 114 | BIO | Bio-Rad Laboratories, Inc. | 8.27B | 1.38% | 32,361 | 2.59B |
| 115 | TECH | Bio-Techne Corporation | 8.21B | 3.14% | 458,793 | 1.21B |
| 116 | CORT | Corcept Therapeutics Incorporated | 8.01B | 2.67% | 125,967 | 769.10M |
| 117 | QGEN | Qiagen N.V. | 7.77B | 3.13% | 563,540 | 2.10B |
| 118 | IBRX | ImmunityBio, Inc. | 7.57B | 0.70% | 1,810,562 | 140.98M |
| 119 | PRAX | Praxis Precision Medicines, Inc. | 7.49B | -3.64% | 254,110 | 7.46M |
| 120 | HQY | HealthEquity, Inc. | 7.39B | 3.70% | 59,766 | 1.34B |
| 121 | ALKS | Alkermes plc | 7.38B | 3.54% | 650,180 | 1.56B |
| 122 | NUVL | Nuvalent, Inc. | 7.36B | 3.34% | 113,265 | - |
| 123 | ATR | AptarGroup, Inc. | 7.29B | 1.48% | 26,168 | 3.87B |
| 124 | RGEN | Repligen Corporation | 7.13B | 3.90% | 126,912 | 763.34M |
| 125 | GKOS | Glaukos Corporation | 7.04B | 5.53% | 294,004 | 551.35M |
| 126 | OSCR | Oscar Health, Inc. | 7.00B | 13.41% | 3,444,350 | 13.30B |
| 127 | PCVX | Vaxcyte, Inc. | 6.95B | 2.57% | 195,258 | - |
| 128 | HIMS | Hims & Hers Health, Inc. | 6.80B | 6.72% | 8,697,927 | 2.37B |
| 129 | SYRE | Spyre Therapeutics, Inc. | 6.76B | 5.82% | 247,862 | - |
| 130 | LNTH | Lantheus Holdings, Inc. | 6.68B | 2.34% | 95,824 | 1.55B |
| 131 | APGE | Apogee Therapeutics, Inc. | 6.64B | 5.30% | 186,165 | - |
| 132 | IMVT | Immunovant, Inc. | 6.62B | 3.47% | 144,291 | - |
| 133 | ABVX | ABIVAX Société Anonyme | 6.59B | 8.75% | 1,553,356 | 5.67M |
| 134 | AVTR | Avantor, Inc. | 6.45B | 4.19% | 1,338,866 | 6.55B |
| 135 | LEGN | Legend Biotech Corporation | 6.44B | -3.61% | 650,033 | 1.14B |
| 136 | PTGX | Protagonist Therapeutics, Inc. | 6.34B | 3.30% | 56,638 | 74.06M |
| 137 | GRFS | Grifols, S.A. | 6.33B | 1.87% | 55,194 | 8.58B |
| 138 | CNTA | Centessa Pharmaceuticals plc | 6.17B | 0.03% | 329,918 | 15.00M |
| 139 | KYMR | Kymera Therapeutics, Inc. | 6.05B | 0.45% | 78,194 | 51.48M |
| 140 | TGTX | TG Therapeutics, Inc. | 5.97B | 5.04% | 736,042 | 700.35M |
| 141 | PACS | PACS Group, Inc. | 5.93B | 2.63% | 43,588 | 5.43B |
| 142 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.93B | 2.10% | 36,791 | 217.17M |
| 143 | PTCT | PTC Therapeutics, Inc. | 5.86B | 2.80% | 100,943 | 827.11M |
| 144 | TFX | Teleflex Incorporated | 5.85B | 2.72% | 50,007 | 2.13B |
| 145 | MIRM | Mirum Pharmaceuticals, Inc. | 5.77B | 3.12% | 51,432 | 569.61M |
| 146 | CHE | Chemed Corporation | 5.76B | 2.09% | 76,267 | 2.54B |
| 147 | LQDA | Liquidia Corporation | 5.74B | 15.93% | 1,277,748 | 288.07M |
| 148 | COGT | Cogent Biosciences, Inc. | 5.66B | 2.67% | 351,867 | - |
| 149 | CRSP | CRISPR Therapeutics AG | 5.62B | 11.81% | 1,075,230 | 4.10M |
| 150 | BLTE | Belite Bio, Inc | 5.61B | 3.88% | 47,664 | - |
| 151 | SRRK | Scholar Rock Holding Corporation | 5.50B | 2.84% | 120,346 | - |
| 152 | BLCO | Bausch + Lomb Corporation | 5.48B | 3.43% | 43,016 | 5.21B |
| 153 | XENE | Xenon Pharmaceuticals Inc. | 5.26B | 1.74% | 365,121 | 7.50M |
| 154 | STVN | Stevanato Group S.p.A. | 5.13B | 1.35% | 16,883 | 1.39B |
| 155 | BLLN | BillionToOne, Inc. | 5.00B | 10.56% | 319,691 | 354.54M |
| 156 | TWST | Twist Bioscience Corporation | 4.89B | 8.50% | 525,715 | 409.48M |
| 157 | CGON | CG Oncology, Inc. | 4.86B | 1.29% | 118,413 | 5.07M |
| 158 | HNGE | Hinge Health, Inc. | 4.86B | 7.04% | 438,786 | 646.34M |
| 159 | CAI | Caris Life Sciences, Inc. | 4.80B | 9.75% | 419,639 | 907.29M |
| 160 | LGND | Ligand Pharmaceuticals Incorporated | 4.79B | 2.01% | 28,111 | 274.48M |
| 161 | DNTH | Dianthus Therapeutics, Inc. | 4.62B | -0.63% | 224,511 | 1.34M |
| 162 | SHC | Sotera Health Company | 4.49B | 3.08% | 351,485 | 1.19B |
| 163 | TXG | 10x Genomics, Inc. | 4.45B | 9.06% | 1,047,790 | 638.78M |
| 164 | CELC | Celcuity Inc. | 4.43B | 2.10% | 1,804,740 | - |
| 165 | TVTX | Travere Therapeutics, Inc. | 4.39B | 4.42% | 544,784 | 536.20M |
| 166 | MANE | Veradermics, Incorporated | 4.31B | 6.69% | 65,105 | - |
| 167 | AMRX | Amneal Pharmaceuticals, Inc. | 4.27B | 4.08% | 409,792 | 3.05B |
| 168 | ERAS | Erasca, Inc. | 4.17B | 1.82% | 1,616,611 | - |
| 169 | MMED | MiniMed Group, Inc. | 4.16B | 3.86% | 310,162 | 3.10B |
| 170 | RDNT | RadNet, Inc. | 4.11B | 0.83% | 274,490 | 2.14B |
| 171 | EWTX | Edgewise Therapeutics, Inc. | 4.07B | 4.45% | 126,678 | - |
| 172 | LIVN | LivaNova PLC | 4.07B | 3.78% | 44,431 | 1.43B |
| 173 | VCYT | Veracyte, Inc. | 4.02B | 3.45% | 440,886 | 541.74M |
| 174 | WAY | Waystar Holding Corp. | 3.92B | 4.74% | 305,893 | 1.16B |
| 175 | DOCS | Doximity, Inc. | 3.92B | 1.85% | 444,821 | 644.86M |
| 176 | NAMS | NewAmsterdam Pharma Company N.V. | 3.85B | 2.62% | 202,542 | 22.57M |
| 177 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.83B | 0.02% | 159,395 | 596.96M |
| 178 | MMSI | Merit Medical Systems, Inc. | 3.81B | 5.36% | 102,112 | 1.54B |
| 179 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.79B | 3.03% | 80,274 | 754.05M |
| 180 | NVST | Envista Holdings Corporation | 3.72B | 1.92% | 455,732 | 2.81B |
| 181 | ACAD | ACADIA Pharmaceuticals Inc. | 3.70B | 0.84% | 212,554 | 1.10B |
| 182 | ORKA | Oruka Therapeutics, Inc. | 3.70B | 7.24% | 211,024 | - |
| 183 | IRTC | iRhythm Holdings, Inc. | 3.67B | 6.69% | 273,358 | 787.85M |
| 184 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.59B | 2.96% | 144,050 | 18.07M |
| 185 | OGN | Organon & Co. | 3.52B | -0.04% | 233,613 | 6.16B |
| 186 | VKTX | Viking Therapeutics, Inc. | 3.46B | 1.60% | 346,282 | - |
| 187 | ICUI | ICU Medical, Inc. | 3.41B | 4.38% | 35,838 | 2.16B |
| 188 | RLAY | Relay Therapeutics, Inc. | 3.36B | 0.65% | 498,046 | 10.68M |
| 189 | BEAM | Beam Therapeutics Inc. | 3.25B | 10.37% | 707,904 | 164.01M |
| 190 | CON | Concentra Group Holdings Parent, Inc. | 3.24B | 2.42% | 104,892 | 2.23B |
| 191 | DNLI | Denali Therapeutics Inc. | 3.24B | 3.76% | 239,010 | - |
| 192 | TNGX | Tango Therapeutics, Inc. | 3.23B | 4.05% | 215,467 | 56.99M |
| 193 | OPCH | Option Care Health, Inc. | 3.20B | -0.78% | 331,588 | 5.67B |
| 194 | ALHC | Alignment Healthcare, Inc. | 3.19B | 8.21% | 1,282,013 | 4.26B |
| 195 | ITGR | Integer Holdings Corporation | 3.17B | 2.62% | 39,773 | 1.86B |
| 196 | RCUS | Arcus Biosciences, Inc. | 3.16B | 5.28% | 89,479 | 236.00M |
| 197 | TLX | Telix Pharmaceuticals Limited | 3.12B | 9.35% | 177,594 | 803.79M |
| 198 | HAE | Haemonetics Corporation | 3.06B | 2.30% | 55,372 | 1.33B |
| 199 | DYN | Dyne Therapeutics, Inc. | 3.05B | 2.50% | 197,986 | - |
| 200 | LFST | LifeStance Health Group, Inc. | 3.02B | 3.87% | 201,110 | 1.49B |
| 201 | WRBY | Warby Parker Inc. | 3.01B | 1.24% | 235,543 | 890.57M |
| 202 | NHC | National HealthCare Corporation | 2.93B | 0.73% | 24,450 | 1.53B |
| 203 | KLRA | Kailera Therapeutics, Inc. | 2.93B | 1.12% | 56,125 | - |
| 204 | GRAL | GRAIL, Inc. | 2.92B | 11.43% | 326,609 | 156.12M |
| 205 | BKD | Brookdale Senior Living Inc. | 2.92B | -0.16% | 428,995 | 3.00B |
| 206 | ADPT | Adaptive Biotechnologies Corporation | 2.81B | 9.69% | 879,014 | 295.41M |
| 207 | GPCR | Structure Therapeutics Inc. | 2.79B | 4.68% | 96,215 | - |
| 208 | IRON | Disc Medicine, Inc. | 2.75B | 2.35% | 96,031 | - |
| 209 | ARQT | Arcutis Biotherapeutics, Inc. | 2.74B | 2.72% | 177,526 | 415.62M |
| 210 | DFTX | Definium Therapeutics, Inc. | 2.70B | 4.96% | 684,949 | - |
| 211 | PRVA | Privia Health Group, Inc. | 2.70B | 3.58% | 117,139 | 2.25B |
| 212 | TARS | Tarsus Pharmaceuticals, Inc. | 2.65B | 4.99% | 43,292 | 535.08M |
| 213 | ALMS | Alumis Inc. | 2.65B | 3.39% | 141,364 | 8.40M |
| 214 | SUPN | Supernus Pharmaceuticals, Inc. | 2.63B | 2.92% | 43,963 | 776.83M |
| 215 | HTFL | HeartFlow, Inc. | 2.62B | 5.20% | 268,495 | 191.42M |
| 216 | GRDN | Guardian Pharmacy Services, Inc. | 2.59B | 4.39% | 97,647 | 1.46B |
| 217 | IDYA | IDEAYA Biosciences, Inc. | 2.58B | 3.24% | 70,871 | 225.27M |
| 218 | TMDX | TransMedics Group, Inc. | 2.50B | 3.99% | 316,677 | 635.89M |
| 219 | ACHC | Acadia Healthcare Company, Inc. | 2.45B | 3.46% | 700,003 | 3.37B |
| 220 | GMRS | GMR Solutions Inc. | 2.43B | 0.23% | 68,268 | 5.74B |
| 221 | CLDX | Celldex Therapeutics, Inc. | 2.40B | 2.54% | 56,271 | 865.00K |
| 222 | VERA | Vera Therapeutics, Inc. | 2.33B | 3.90% | 79,485 | - |
| 223 | RARE | Ultragenyx Pharmaceutical Inc. | 2.29B | 3.97% | 181,718 | 670.00M |
| 224 | AXGN | Axogen, Inc. | 2.28B | 5.35% | 124,029 | 238.11M |
| 225 | IMNM | Immunome, Inc. | 2.28B | 1.41% | 232,434 | 4.02M |
| 226 | ESTA | Establishment Labs Holdings Inc. | 2.26B | 6.01% | 138,658 | 229.58M |
| 227 | ELVN | Enliven Therapeutics, Inc. | 2.24B | 2.28% | 147,735 | - |
| 228 | PBH | Prestige Consumer Healthcare Inc. | 2.21B | 2.49% | 64,952 | 1.09B |
| 229 | KOD | Kodiak Sciences Inc. | 2.18B | 2.92% | 166,117 | - |
| 230 | LMAT | LeMaitre Vascular, Inc. | 2.16B | 2.97% | 50,241 | 256.28M |
| 231 | PHVS | Pharvaris N.V. | 2.15B | 2.52% | 38,745 | - |
| 232 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.15B | 2.42% | 586,091 | 885.72M |
| 233 | NTLA | Intellia Therapeutics, Inc. | 2.11B | 16.21% | 2,411,230 | 66.09M |
| 234 | AUPH | Aurinia Pharmaceuticals Inc. | 2.11B | 4.79% | 811,260 | 298.30M |
| 235 | MLYS | Mineralys Therapeutics, Inc. | 2.09B | 1.12% | 530,978 | - |
| 236 | RXRX | Recursion Pharmaceuticals, Inc. | 2.08B | 12.68% | 12,066,330 | 66.41M |
| 237 | CLOV | Clover Health Investments, Corp. | 2.06B | 7.40% | 2,362,566 | 2.21B |
| 238 | NVCR | NovoCure Limited | 2.06B | 10.34% | 404,864 | 674.41M |
| 239 | SEM | Select Medical Holdings Corporation | 2.05B | 0.18% | 58,027 | 5.52B |
| 240 | NKTR | Nektar Therapeutics | 2.04B | 2.09% | 266,883 | 55.63M |
| 241 | PGNY | Progyny, Inc. | 2.02B | 3.44% | 131,199 | 1.29B |
| 242 | HCM | HUTCHMED (China) Limited | 2.02B | -0.62% | 8,171 | 548.51M |
| 243 | OMCL | Omnicell, Inc. | 2.00B | 4.77% | 59,050 | 1.23B |
| 244 | NEOG | Neogen Corporation | 1.99B | 3.75% | 449,135 | 870.56M |
| 245 | TRVI | Trevi Therapeutics, Inc. | 1.97B | 3.42% | 158,551 | - |
| 246 | XRAY | DENTSPLY SIRONA Inc. | 1.96B | 1.56% | 1,075,054 | 3.68B |
| 247 | ZLAB | Zai Lab Limited | 1.95B | 1.28% | 137,385 | 453.28M |
| 248 | OCUL | Ocular Therapeutix, Inc. | 1.93B | 5.75% | 419,515 | 52.04M |
| 249 | ABCL | AbCellera Biologics Inc. | 1.93B | 10.58% | 2,255,344 | 79.21M |
| 250 | PLSE | Pulse Biosciences, Inc. | 1.93B | 11.36% | 241,238 | 751.00K |
| 251 | BHC | Bausch Health Companies Inc. | 1.92B | 4.04% | 816,169 | 10.53B |
| 252 | IOVA | Iovance Biotherapeutics, Inc. | 1.91B | 13.06% | 4,839,064 | 285.61M |
| 253 | STOK | Stoke Therapeutics, Inc. | 1.90B | 3.60% | 120,577 | 32.08M |
| 254 | HRMY | Harmony Biosciences Holdings, Inc. | 1.90B | 2.18% | 74,307 | 899.11M |
| 255 | GENB | Generate Biomedicines, Inc. | 1.89B | 14.25% | 897,237 | 30.30M |
| 256 | ASTH | Astrana Health, Inc. | 1.89B | 3.90% | 45,076 | 3.53B |
| 257 | QURE | uniQure N.V. | 1.87B | -0.60% | 579,231 | 18.09M |
| 258 | MESO | Mesoblast Limited | 1.87B | 3.72% | 34,023 | 65.38M |
| 259 | ADMA | ADMA Biologics, Inc. | 1.86B | 3.35% | 517,103 | 509.86M |
| 260 | CMPS | COMPASS Pathways plc | 1.85B | 7.96% | 1,492,046 | - |
| 261 | VRDN | Viridian Therapeutics, Inc. | 1.85B | 2.39% | 189,145 | 70.92M |
| 262 | VCEL | Vericel Corporation | 1.85B | 4.09% | 118,321 | 292.09M |
| 263 | MD | Pediatrix Medical Group, Inc. | 1.82B | 4.17% | 88,397 | 1.93B |
| 264 | RAPP | Rapport Therapeutics, Inc. | 1.82B | 3.08% | 38,884 | 20.00M |
| 265 | ZYME | Zymeworks Inc. | 1.82B | 2.40% | 57,065 | 81.26M |
| 266 | SGRY | Surgery Partners, Inc. | 1.80B | 2.59% | 220,289 | 3.34B |
| 267 | LKFT | Lakefront Biotherapeutics NV | 1.79B | 1.96% | 29,855 | 1.20B |
| 268 | NUVB | Nuvation Bio Inc. | 1.78B | 8.05% | 906,603 | 143.05M |
| 269 | NBTX | Nanobiotix S.A. | 1.77B | 1.53% | 6,658 | 38.27M |
| 270 | SRPT | Sarepta Therapeutics, Inc. | 1.76B | 2.77% | 397,124 | 2.18B |
| 271 | UFPT | UFP Technologies, Inc. | 1.75B | 3.82% | 38,357 | 608.85M |
| 272 | SION | Sionna Therapeutics, Inc. | 1.72B | 4.03% | 94,429 | - |
| 273 | ATAI | AtaiBeckley Inc. | 1.72B | 3.53% | 1,103,786 | 3.49M |
| 274 | TYRA | Tyra Biosciences, Inc. | 1.72B | 0.63% | 82,239 | - |
| 275 | AGIO | Agios Pharmaceuticals, Inc. | 1.71B | 3.79% | 65,939 | 66.05M |
| 276 | AAPG | Ascentage Pharma Group International | 1.69B | 1.96% | 1,569 | 82.08M |
| 277 | NVAX | Novavax, Inc. | 1.68B | 0.44% | 1,114,237 | 596.34M |
| 278 | BHVN | Biohaven Ltd. | 1.67B | 2.68% | 824,459 | - |
| 279 | GHRS | GH Research PLC | 1.67B | -0.37% | 109,431 | - |
| 280 | ANIP | ANI Pharmaceuticals, Inc. | 1.66B | 4.33% | 79,801 | 923.71M |
| 281 | TSHA | Taysha Gene Therapies, Inc. | 1.66B | 4.05% | 183,285 | 7.47M |
| 282 | ADUS | Addus HomeCare Corporation | 1.65B | 1.93% | 34,221 | 1.45B |
| 283 | INVA | Innoviva, Inc. | 1.65B | 2.86% | 66,080 | 420.69M |
| 284 | CAPR | Capricor Therapeutics, Inc. | 1.64B | 2.42% | 92,881 | 11.13M |
| 285 | PVLA | Palvella Therapeutics, Inc. | 1.64B | -1.14% | 26,895 | - |
| 286 | WGS | GeneDx Holdings Corp. | 1.63B | 3.72% | 320,607 | 442.68M |
| 287 | SLS | SELLAS Life Sciences Group, Inc. | 1.63B | 7.14% | 2,046,583 | - |
| 288 | FTRE | Fortrea Holdings Inc. | 1.61B | 9.15% | 814,076 | 2.71B |
| 289 | SNDA | Sonida Senior Living, Inc. | 1.60B | 2.29% | 120,957 | 367.34M |
| 290 | SNDX | Syndax Pharmaceuticals, Inc. | 1.59B | -2.07% | 3,560,807 | 217.17M |
| 291 | NRIX | Nurix Therapeutics, Inc. | 1.59B | -0.65% | 507,446 | 71.78M |
| 292 | AGL | agilon health, inc. | 1.57B | 13.66% | 76,330 | 5.82B |
| 293 | PRCT | PROCEPT BioRobotics Corporation | 1.55B | 3.68% | 150,045 | 322.02M |
| 294 | VIR | Vir Biotechnology, Inc. | 1.54B | 4.10% | 298,837 | 65.50M |
| 295 | AVAH | Aveanna Healthcare Holdings Inc. | 1.53B | 3.83% | 311,179 | 2.52B |
| 296 | ALMR | Alamar Biosciences, Inc. | 1.53B | 5.16% | 30,433 | 87.16M |
| 297 | GLUE | Monte Rosa Therapeutics, Inc. | 1.51B | 1.82% | 99,959 | 42.95M |
| 298 | ANAB | AnaptysBio, Inc. | 1.51B | 1.23% | 45,600 | 232.39M |
| 299 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.50B | 2.27% | 206,039 | -665.00K |
| 300 | IMCR | Immunocore Holdings plc | 1.50B | 2.79% | 81,550 | 412.81M |
| 301 | PRGO | Perrigo Company plc | 1.48B | 2.49% | 346,080 | 4.18B |
| 302 | NEO | NeoGenomics, Inc. | 1.47B | 11.14% | 252,275 | 745.97M |
| 303 | STAA | STAAR Surgical Company | 1.45B | 3.17% | 57,016 | 290.38M |
| 304 | MBX | MBX Biosciences, Inc. | 1.45B | 1.03% | 44,957 | - |
| 305 | AVBP | ArriVent BioPharma, Inc. | 1.44B | 3.56% | 58,325 | - |
| 306 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | - | 451,027 | 114.48M |
| 307 | HCSG | Healthcare Services Group, Inc. | 1.42B | 2.77% | 76,149 | 1.85B |
| 308 | MAZE | Maze Therapeutics, Inc. | 1.41B | 2.74% | 120,888 | 20.00M |
| 309 | IMTX | Immatics N.V. | 1.41B | 2.99% | 92,135 | 43.00M |
| 310 | ATRC | AtriCure, Inc. | 1.41B | 5.95% | 111,733 | 552.16M |
| 311 | SEPN | Septerna, Inc. | 1.40B | 1.41% | 28,625 | 72.26M |
| 312 | PGEN | Precigen, Inc. | 1.39B | 2.23% | 930,945 | 31.60M |
| 313 | INBX | Inhibrx Biosciences, Inc. | 1.38B | -1.19% | 77,098 | 1.30M |
| 314 | BLFS | BioLife Solutions, Inc. | 1.37B | 2.75% | 72,450 | 101.66M |
| 315 | DMRA | Damora Therapeutics, Inc. | 1.37B | -0.49% | 149,137 | - |
| 316 | SVRA | Savara Inc. | 1.37B | 2.67% | 188,808 | - |
| 317 | MPLT | MapLight Therapeutics, Inc. | 1.36B | 5.79% | 48,264 | - |
| 318 | MLTX | MoonLake Immunotherapeutics | 1.36B | 0.99% | 39,581 | - |
| 319 | PAHC | Phibro Animal Health Corporation | 1.35B | 4.75% | 97,098 | 1.50B |
| 320 | BCAX | Bicara Therapeutics Inc. | 1.35B | 2.75% | 22,123 | - |
| 321 | ARDX | Ardelyx, Inc. | 1.35B | 0.55% | 569,533 | 427.68M |
| 322 | TDOC | Teladoc Health, Inc. | 1.34B | 5.08% | 933,088 | 2.51B |
| 323 | URGN | UroGen Pharma Ltd. | 1.33B | 2.80% | 26,848 | 140.49M |
| 324 | TNDM | Tandem Diabetes Care, Inc. | 1.33B | 7.76% | 414,179 | 1.03B |
| 325 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.32B | 5.99% | 733,568 | 204.73M |
| 326 | IART | Integra LifeSciences Holdings Corporation | 1.32B | 5.68% | 80,316 | 1.64B |
| 327 | AHCO | AdaptHealth Corp. | 1.32B | 2.06% | 204,872 | 3.29B |
| 328 | HROW | Harrow, Inc. | 1.31B | 5.36% | 85,265 | 268.68M |
| 329 | ENOV | Enovis Corporation | 1.30B | 4.62% | 131,362 | 2.28B |
| 330 | PSNL | Personalis, Inc. | 1.29B | 14.47% | 1,828,343 | 64.52M |
| 331 | BFLY | Butterfly Network, Inc. | 1.28B | 11.39% | 1,123,108 | 102.92M |
| 332 | AHG | Akso Health Group | 1.24B | - | 198 | 14.84M |
| 333 | AMN | AMN Healthcare Services, Inc. | 1.23B | 4.59% | 100,975 | 3.42B |
| 334 | ATEC | Alphatec Holdings, Inc. | 1.23B | 3.78% | 546,080 | 787.08M |
| 335 | CDNA | CareDx, Inc. | 1.22B | 6.28% | 315,093 | 412.82M |
| 336 | SDGR | Schrödinger, Inc. | 1.22B | 9.18% | 675,534 | 254.91M |
| 337 | NNNN | Anbio Biotechnology | 1.21B | -2.91% | 1,743 | 8.65M |
| 338 | IRMD | IRADIMED CORPORATION | 1.21B | 4.26% | 13,706 | 86.28M |
| 339 | KMTS | Kestra Medical Technologies, Ltd. | 1.21B | 9.99% | 204,787 | 83.72M |
| 340 | INSP | Inspire Medical Systems, Inc. | 1.21B | 3.59% | 124,150 | 915.25M |
| 341 | ARDT | Ardent Health, Inc. | 1.19B | 6.26% | 274,640 | 6.43B |
| 342 | WVE | Wave Life Sciences Ltd. | 1.18B | 6.42% | 915,033 | 71.80M |
| 343 | AVNS | Avanos Medical, Inc. | 1.17B | 0.04% | 175,150 | 715.90M |
| 344 | ZBIO | Zenas BioPharma, Inc. | 1.17B | 6.15% | 189,778 | 10.00M |
| 345 | COAG | Hemab Therapeutics Holdings, Inc. | 1.16B | -0.08% | 12,432 | - |
| 346 | AKTS | Aktis Oncology, Inc. | 1.15B | 7.07% | 21,447 | 8.28M |
| 347 | AVLN | Avalyn Pharma Inc. | 1.14B | 3.41% | 27,026 | - |
| 348 | ABSI | Absci Corporation | 1.12B | 20.96% | 2,904,920 | 1.84M |
| 349 | AZTA | Azenta, Inc. | 1.10B | 0.33% | 257,776 | 596.48M |
| 350 | ALVO | Alvotech | 1.10B | 12.10% | 275,335 | 562.04M |
| 351 | OPK | OPKO Health, Inc. | 1.10B | -0.34% | 658,565 | 581.12M |
| 352 | EYPT | EyePoint, Inc. | 1.09B | 5.35% | 120,981 | 7.61M |
| 353 | OMDA | Omada Health, Inc. | 1.09B | 5.60% | 111,262 | 283.30M |
| 354 | PNTG | The Pennant Group, Inc. | 1.08B | 2.31% | 48,852 | 1.02B |
| 355 | CNMD | CONMED Corporation | 1.07B | 7.08% | 80,458 | 1.37B |
| 356 | XERS | Xeris Biopharma Holdings, Inc. | 1.05B | 3.65% | 338,158 | 314.85M |
| 357 | DBVT | DBV Technologies S.A. | 1.04B | -0.85% | 78,892 | 5.74M |
| 358 | MNKD | MannKind Corporation | 1.04B | - | 581,694 | 360.78M |
| 359 | EVO | Evotec SE | 1.04B | 2.08% | 3,999 | 859.03M |
| 360 | COLL | Collegium Pharmaceutical, Inc. | 1.04B | 2.90% | 43,271 | 796.33M |
| 361 | QDEL | QuidelOrtho Corporation | 1.03B | 11.29% | 338,202 | 2.66B |
| 362 | AORT | Artivion, Inc. | 1.03B | 2.87% | 213,248 | 458.69M |
| 363 | CRON | Cronos Group Inc. | 1.01B | 3.32% | 324,393 | 159.54M |
| 364 | GDRX | GoodRx Holdings, Inc. | 1.01B | 6.05% | 250,654 | 787.89M |
| 365 | CRVS | Corvus Pharmaceuticals, Inc. | 995.63M | 2.07% | 131,575 | - |
| 366 | INNV | InnovAge Holding Corp. | 984.09M | 2.40% | 7,840 | 949.17M |
| 367 | USPH | U.S. Physical Therapy, Inc. | 972.78M | 3.31% | 40,217 | 787.69M |
| 368 | DRTS | Alpha Tau Medical Ltd. | 955.87M | 0.19% | 665,314 | - |
| 369 | NUTX | Nutex Health Inc. | 949.76M | 3.91% | 30,575 | 879.95M |
| 370 | OLMA | Olema Pharmaceuticals, Inc. | 942.48M | 2.66% | 136,298 | - |
| 371 | CGEM | Cullinan Therapeutics, Inc. | 939.08M | 0.46% | 318,860 | - |
| 372 | SPTX | Seaport Therapeutics, Inc. | 934.35M | 2.26% | 32,512 | - |
| 373 | ANNX | Annexon, Inc. | 906.05M | 2.60% | 1,004,926 | - |
| 374 | CERT | Certara, Inc. | 900.72M | 3.39% | 764,438 | 419.75M |
| 375 | PCRX | Pacira BioSciences, Inc. | 900.28M | 2.51% | 126,737 | 734.86M |
| 376 | SPRY | ARS Pharmaceuticals, Inc. | 889.76M | 2.40% | 142,939 | 98.99M |
| 377 | XNCR | Xencor, Inc. | 889.70M | 5.08% | 101,514 | 97.36M |
| 378 | SANA | Sana Biotechnology, Inc. | 889.14M | 2.40% | 986,364 | - |
| 379 | MGTX | MeiraGTx Holdings plc | 889.05M | 2.24% | 75,374 | 79.76M |
| 380 | LXRX | Lexicon Pharmaceuticals, Inc. | 879.51M | 7.03% | 432,385 | 69.64M |
| 381 | JBIO | Jade Biosciences, Inc. | 877.12M | 1.02% | 1,338,610 | - |
| 382 | TALK | Talkspace, Inc. | 873.58M | 0.10% | 197,929 | 238.37M |
| 383 | PHAR | Pharming Group N.V. | 866.52M | 1.96% | 6,276 | 369.49M |
| 384 | INMD | InMode Ltd. | 862.95M | 0.96% | 106,774 | 374.64M |
| 385 | SSII | SS Innovations International, Inc. | 859.74M | -0.23% | 20,779 | 48.47M |
| 386 | JANX | Janux Therapeutics, Inc. | 855.00M | 3.16% | 107,453 | 13.73M |
| 387 | ABUS | Arbutus Biopharma Corporation | 854.35M | -0.57% | 242,709 | 191.45M |
| 388 | REPL | Replimune Group, Inc. | 843.89M | 2.40% | 2,373,700 | - |
| 389 | ORIC | ORIC Pharmaceuticals, Inc. | 841.60M | 3.70% | 203,934 | - |
| 390 | TBPH | Theravance Biopharma, Inc. | 837.74M | 2.07% | 68,064 | 109.78M |
| 391 | AVR | Anteris Technologies Global Corp. | 833.55M | 13.13% | 299,931 | 1.85M |
| 392 | LBRX | LB Pharmaceuticals Inc | 828.76M | 3.40% | 36,795 | - |
| 393 | AMPH | Amphastar Pharmaceuticals, Inc. | 827.62M | 3.59% | 61,323 | 720.53M |
| 394 | IVA | Inventiva S.A. | 817.33M | 9.41% | 510,706 | 7.94M |
| 395 | LMRI | Lumexa Imaging Holdings, Inc. | 811.88M | 8.75% | 109,519 | 1.03B |
| 396 | PHAT | Phathom Pharmaceuticals, Inc. | 810.98M | 1.19% | 104,048 | 204.89M |
| 397 | ESPR | Esperion Therapeutics, Inc. | 807.05M | -0.16% | 1,666,141 | 418.24M |
| 398 | VOR | Vor Biopharma Inc. | 798.70M | 9.67% | 301,635 | - |
| 399 | KURA | Kura Oncology, Inc. | 797.19M | 3.76% | 336,389 | 71.64M |
| 400 | ETON | Eton Pharmaceuticals, Inc. | 791.09M | 4.60% | 75,769 | 86.93M |
| 401 | ODTX | Odyssey Therapeutics, Inc. | 787.34M | - | 6,160 | 2.98M |
| 402 | OMER | Omeros Corporation | 774.42M | 5.31% | 211,827 | 9.89M |
| 403 | GERN | Geron Corporation | 773.03M | 3.88% | 2,713,609 | 196.12M |
| 404 | AURA | Aura Biosciences, Inc. | 772.65M | 1.82% | 89,464 | - |
| 405 | OCS | Oculis Holding AG | 760.29M | -4.19% | 118,311 | 1.40M |
| 406 | EVMN | Evommune, Inc. | 749.90M | 5.52% | 142,532 | 10.00M |
| 407 | HSTM | HealthStream, Inc. | 749.37M | 4.52% | 31,578 | 311.78M |
| 408 | DRUG | Bright Minds Biosciences Inc. | 749.19M | -0.82% | 219,465 | - |
| 409 | AVTX | Avalo Therapeutics, Inc. | 745.38M | 3.20% | 303,192 | 59.00K |
| 410 | BVS | Bioventus Inc. | 741.79M | 3.86% | 164,957 | 576.30M |
| 411 | BIOA | BioAge Labs, Inc. | 740.58M | 3.87% | 27,129 | 10.32M |
| 412 | SLDB | Solid Biosciences Inc. | 721.64M | 7.01% | 218,435 | - |
| 413 | ALLO | Allogene Therapeutics, Inc. | 719.65M | 4.25% | 1,265,981 | 22.00K |
| 414 | CTMX | CytomX Therapeutics, Inc. | 704.27M | 0.47% | 492,334 | 35.54M |
| 415 | CBLL | CeriBell, Inc. | 701.18M | 7.57% | 129,436 | 95.07M |
| 416 | ANRO | Alto Neuroscience, Inc. | 679.32M | 2.81% | 37,261 | - |
| 417 | TENX | Tenax Therapeutics, Inc. | 677.10M | 6.78% | 152,381 | - |
| 418 | DSGN | Design Therapeutics, Inc. | 674.54M | 3.45% | 47,645 | - |
| 419 | CADL | Candel Therapeutics, Inc. | 671.16M | 4.09% | 569,766 | - |
| 420 | SIBN | SI-BONE, Inc. | 670.56M | 8.62% | 71,141 | 206.22M |
| 421 | CRMD | CorMedix Inc. | 668.41M | 3.52% | 365,393 | 400.05M |
| 422 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 663.29M | 3.11% | 13,078 | - |
| 423 | DNA | Ginkgo Bioworks Holdings, Inc. | 662.39M | 16.15% | 1,231,014 | 151.40M |
| 424 | ZVRA | Zevra Therapeutics, Inc. | 662.09M | 2.19% | 219,994 | 122.29M |
| 425 | RLMD | Relmada Therapeutics, Inc. | 661.86M | -0.32% | 136,911 | - |
| 426 | CSTL | Castle Biosciences, Inc. | 649.36M | 5.00% | 85,227 | 339.92M |
| 427 | PRME | Prime Medicine, Inc. | 643.90M | 13.54% | 1,442,640 | 4.03M |
| 428 | ACRS | Aclaris Therapeutics, Inc. | 641.06M | 3.85% | 103,709 | 8.37M |
| 429 | SGP | SpyGlass Pharma, Inc. | 639.45M | 3.07% | 4,946 | - |
| 430 | TLRY | Tilray Brands, Inc. | 623.25M | 2.25% | 1,070,013 | 858.28M |
| 431 | PHR | Phreesia, Inc. | 619.97M | 3.94% | 163,500 | 495.59M |
| 432 | IMMX | Immix Biopharma, Inc. | 614.86M | 4.38% | 410,894 | - |
| 433 | CBIO | Crescent Biopharma, Inc. | 614.41M | 2.84% | 22,440 | 11.88M |
| 434 | BBNX | Beta Bionics, Inc. | 605.15M | 9.08% | 214,604 | 110.24M |
| 435 | AGMB | AgomAb Therapeutics NV | 603.78M | 2.17% | 23,259 | - |
| 436 | ALT | Altimmune, Inc. | 576.62M | 3.31% | 621,017 | 36.00K |
| 437 | TCMD | Tactile Systems Technology, Inc. | 573.83M | 4.39% | 37,900 | 343.52M |
| 438 | TRAX | First Tracks Biotherapeutics, Inc. | 573.46M | 7.28% | 56,633 | - |
| 439 | NPCE | NeuroPace, Inc. | 570.05M | 5.29% | 23,287 | 99.53M |
| 440 | IRWD | Ironwood Pharmaceuticals, Inc. | 564.62M | 5.86% | 804,605 | 361.51M |
| 441 | BWAY | BrainsWay Ltd. | 563.12M | 1.46% | 13,653 | 56.22M |
| 442 | CERS | Cerus Corporation | 561.03M | 5.26% | 1,214,668 | 216.56M |
| 443 | GYRE | Gyre Therapeutics, Inc. | 561.02M | 7.91% | 47,503 | 117.05M |
| 444 | RIGL | Rigel Pharmaceuticals, Inc. | 560.98M | 0.07% | 45,260 | 299.77M |
| 445 | CTKB | Cytek Biosciences, Inc. | 560.48M | 7.16% | 138,394 | 204.17M |
| 446 | CABA | Cabaletta Bio, Inc. | 559.28M | -4.19% | 592,223 | - |
| 447 | TECX | Tectonic Therapeutic, Inc. | 557.11M | 3.89% | 7,168 | - |
| 448 | MDXG | MiMedx Group, Inc. | 555.57M | 3.32% | 298,034 | 389.42M |
| 449 | SRTA | Strata Critical Medical, Inc. | 549.44M | 2.25% | 145,614 | 228.58M |
| 450 | FLGT | Fulgent Genetics, Inc. | 547.56M | 6.28% | 81,329 | 320.35M |
| 451 | PROK | ProKidney Corp. | 546.73M | 4.62% | 182,137 | 889.00K |
| 452 | PACB | Pacific Biosciences of California, Inc. | 540.45M | 10.13% | 2,614,152 | 160.03M |
| 453 | FDMT | 4D Molecular Therapeutics, Inc. | 536.88M | 7.76% | 218,257 | 88.24M |
| 454 | EIKN | Eikon Therapeutics, Inc. | 536.51M | 5.09% | 33,896 | - |
| 455 | ACHV | Achieve Life Sciences, Inc. | 530.75M | 5.08% | 295,953 | - |
| 456 | AQST | Aquestive Therapeutics, Inc. | 528.15M | 4.47% | 882,468 | 50.27M |
| 457 | XOMA | XOMA Royalty Corporation | 525.47M | 0.48% | 43,907 | 48.56M |
| 458 | CLYM | Climb Bio, Inc. | 524.74M | 5.22% | 283,483 | - |
| 459 | VALN | Valneva SE | 523.48M | 2.87% | 1,747 | 180.25M |
| 460 | STRO | Sutro Biopharma, Inc. | 507.22M | 12.62% | 38,034 | 99.61M |
| 461 | ARVN | Arvinas, Inc. | 505.85M | 1.82% | 116,633 | 89.40M |
| 462 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 463 | ANGO | AngioDynamics, Inc. | 488.93M | 4.73% | 26,897 | 313.73M |
| 464 | PRTA | Prothena Corporation plc | 488.46M | 4.60% | 141,714 | 57.94M |
| 465 | ASMB | Assembly Biosciences, Inc. | 483.14M | -0.77% | 42,722 | 71.10M |
| 466 | KYTX | Kyverna Therapeutics, Inc. | 481.82M | 1.79% | 144,338 | - |
| 467 | CTEV | Claritev Corporation | 481.43M | 7.50% | 18,078 | 978.76M |
| 468 | CCCC | C4 Therapeutics, Inc. | 477.08M | 9.34% | 445,502 | 34.86M |
| 469 | LAB | Standard BioTools Inc. | 476.25M | 7.02% | 877,065 | 86.26M |
| 470 | EVH | Evolent Health, Inc. | 475.23M | 11.77% | 1,008,570 | 1.89B |
| 471 | KIDS | OrthoPediatrics Corp. | 471.58M | 8.51% | 15,942 | 243.30M |
| 472 | TOI | The Oncology Institute, Inc. | 469.92M | 11.11% | 565,773 | 545.76M |
| 473 | EDIT | Editas Medicine, Inc. | 467.29M | 9.53% | 899,649 | 38.69M |
| 474 | WEAV | Weave Communications, Inc. | 467.05M | 3.35% | 108,362 | 248.72M |
| 475 | OVID | Ovid Therapeutics Inc. | 466.60M | 4.60% | 409,426 | 7.12M |
| 476 | CTNM | Contineum Therapeutics, Inc. | 465.83M | -0.16% | 23,606 | - |
| 477 | AUTL | Autolus Therapeutics plc | 465.75M | 8.02% | 378,490 | 92.62M |
| 478 | RZLT | Rezolute, Inc. | 465.40M | -2.73% | 536,732 | - |
| 479 | OCGN | Ocugen, Inc. | 462.08M | 5.00% | 1,122,634 | 4.47M |
| 480 | NRC | NRC Health | 447.13M | 4.20% | 4,347 | 138.64M |
| 481 | VREX | Varex Imaging Corporation | 446.33M | 4.33% | 62,035 | 857.50M |
| 482 | MYGN | Myriad Genetics, Inc. | 444.85M | 7.05% | 238,569 | 829.00M |
| 483 | ANL | Adlai Nortye Ltd. | 444.40M | -1.33% | 11,027 | 5.00M |
| 484 | SGMT | Sagimet Biosciences Inc. | 444.00M | 4.81% | 118,573 | - |
| 485 | NGNE | Neurogene Inc. | 437.87M | 5.68% | 13,111 | 925.00K |
| 486 | KMDA | Kamada Ltd. | 427.08M | 0.14% | 16,140 | 181.68M |
| 487 | VTVT | vTv Therapeutics Inc. | 425.21M | 4.02% | 17,777 | 36.84M |
| 488 | EBS | Emergent BioSolutions Inc. | 424.64M | 3.78% | 138,477 | 676.80M |
| 489 | FBRX | Forte Biosciences, Inc. | 422.49M | 1.71% | 27,148 | - |
| 490 | EPRX | Eupraxia Pharmaceuticals Inc. | 417.39M | 1.11% | 152,440 | - |
| 491 | EOLS | Evolus, Inc. | 416.86M | 4.98% | 64,349 | 301.79M |
| 492 | UPB | Upstream Bio, Inc. | 416.31M | 0.26% | 138,132 | 3.32M |
| 493 | CLPT | ClearPoint Neuro, Inc. | 415.96M | 4.29% | 181,181 | 40.61M |
| 494 | OFIX | Orthofix Medical Inc. | 413.51M | 5.25% | 75,293 | 825.37M |
| 495 | MNPR | Monopar Therapeutics Inc. | 413.28M | 1.87% | 12,432 | - |
| 496 | MOBI | Mobia Medical, Inc. | 413.24M | -9.03% | 66,211 | 32.04M |
| 497 | CCRN | Cross Country Healthcare, Inc. | 407.76M | 0.23% | 672,357 | 1.00B |
| 498 | CNXU | Conexeu Sciences Inc. | 406.85M | -4.45% | 26,726 | - |
| 499 | CATX | Perspective Therapeutics, Inc. | 403.15M | -0.70% | 207,490 | 618.00K |
| 500 | PRLD | Prelude Therapeutics Incorporated | 400.68M | 10.38% | 116,981 | 16.72M |